Viemed Healthcare (NASDAQ:VMD) Insider William Frazier Sells 10,000 Shares

Viemed Healthcare, Inc. (NASDAQ:VMD) insider William Frazier sold 10,000 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the transaction, the insider owned 73,214 shares of the company’s stock, valued at $858,068.08. This trade represents a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Viemed Healthcare Trading Down 0.5%

Viemed Healthcare stock opened at $11.63 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.22. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $11.88. The stock has a market cap of $445.86 million, a P/E ratio of 31.43 and a beta of 1.12. The firm’s fifty day moving average price is $9.91 and its 200-day moving average price is $8.84.

Viemed Healthcare (NASDAQ:VMD) last posted its earnings results on Tuesday, May 5th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.03). The business had revenue of $75.41 million for the quarter, compared to analysts’ expectations of $74.40 million. Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%. Equities research analysts forecast that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of VMD. Wasatch Advisors LP lifted its position in Viemed Healthcare by 18.4% during the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock valued at $10,683,000 after purchasing an additional 240,346 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Viemed Healthcare by 3.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,447,033 shares of the company’s stock worth $10,751,000 after buying an additional 49,962 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Viemed Healthcare by 2.0% in the 2nd quarter. Geode Capital Management LLC now owns 798,515 shares of the company’s stock worth $5,519,000 after buying an additional 15,353 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in shares of Viemed Healthcare by 101.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock valued at $6,550,000 after buying an additional 358,863 shares in the last quarter. Finally, State Street Corp lifted its holdings in shares of Viemed Healthcare by 1.7% during the 4th quarter. State Street Corp now owns 675,190 shares of the company’s stock worth $5,017,000 after acquiring an additional 11,385 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.